RSS   Newsletter   Contact   Advertise with us
Post Online Media

Endocyte appoints Michael T. Andriole as CFO

EndocyteEndocyte, a biopharmaceutical company, announced that Michael T. Andriole has been appointed as chief financial officer.
Article continues below

READ MORE Endocyte appoints Mike Sherman as president and CEO

Mr. Andriole has more than 20 years of experience in a range of financial, strategic and corporate development roles, including 16 years at Eli Lilly and Company, most recently as Vice President, Corporate Business Development.

While with Eli Lilly and Company, Mr. Andriole was a member of Lilly’s corporate development leadership team with responsibility for international transactions, including in/out licensing, JV formation and M&A.

Mr. Andriole graduated cum laude from Xavier University's Williams College of Business and earned his M.B.A. from Indiana University's Kelley School of Business.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy